<DOC>
	<DOCNO>NCT01250405</DOCNO>
	<brief_summary>The primary objective determine whether reduction serum calcium concentration cinacalcet lead reduction mean blood pressure adjust c-fPWV . The secondary objective study effect calcium reduction 1 ) carotid-radial PWV ( c-rPWV ) , 2 ) common carotid artery ( CCA ) biomechanics , 3 ) pulse wave profile cardiac function .</brief_summary>
	<brief_title>Acute Effects Cinacalcet Arterial Stiffness Ventricular Function Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>chronic ( &gt; 3 month ) hemodialysis population &gt; 18 year old PTH &gt; 300 ng/L correct Ca &gt; 2.10 mmol/L stable hypertensive drug ( &gt; 1 month ) stable dos phosphate binder dialysis calcium concentration palpable femoral pulse systolic BP 90180 mmHg expect survival &gt; 6 month hemodialysis &gt; 3 year acute infection history myocardial infarction stroke within past 3 month inability consent intolerance cinacalcet inadequate birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>